Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are being used increasingly for the management of type 2 diabetes mellitus (T2DM) or obesity because of their association with robust glucose lowering, weight loss, and cardiorenal benefits
Yabe D, Nakamura J, Kaneto H, Deenadayalan S, Navarria A, Gislum M, Inagaki N
Vascular endothelial growth factor (VEGF) is one particularly popular growth factor that is incorporated into scaffolds, as it is believed that even on its own, VEGF is capable of inducing angiogenesis (Gigliobianco et al., 2015
Ad Age recently sat down with Weight Watchers' Chief Marketing & Consumer Strategy Officer Nina George to discuss our recent transformation-- including a new brand, new app experience and integrated features to help members, whether on GLP-1s or not
8 , e49976 (2013)
Bulletin of Experimental Biology and Medicine, 135(6), 590592